Price Anna M, Sarween Nadia, Gupta Itisha, Baharani Jyoti
Department of Nephrology, Birmingham Heartlands Hospital, Birmingham, United Kingdom.
Department of Microbiology, Birmingham Public Health Laboratory, Public Health England and Heart of England Foundation Trust, Birmingham, United Kingdom.
Saudi J Kidney Dis Transpl. 2019 Nov-Dec;30(6):1351-1363. doi: 10.4103/1319-2442.275479.
Patients with end-stage renal disease are susceptible to infection, particularly methicillin-resistant Staphylococcus aureus (MRSA). Although MRSA-related mortality and morbidity have been studied, methicillin-sensitive Staphylococcus aureus (MSSA) has not been investigated to the same degree. Five hundred and seventy-eight chronic hemodialysis patients were followed up retrospectively for 18 months. Routine screening for MRSA and MSSA was instigated. Two hundred and eighty-eight patients (49%) had at least one positive MSSA or MRSA swab. There was no statistical difference in age, Charlson index, diabetes, sex, ethnicity, deprivation index, or the duration of dialysis between the positive and negative groups. There were however, less fistulas and more lines in the positive patients (P = 0.025). Binary logistic regression revealed patients with a body mass index of greater than 30 had a significantly increased risk of Staphylococcus aureus colonization P = 0.044, odds ratio (OR) 1.856 (95% confidence interval 1.016-3.397). Those who entered the study using a temporary line for vascular access also conferred a greater risk of colonization P = 0.029, OR 2.174 (95% CI 1.084-4.359). Patients with positive swabs had significantly more admissions (P = 0.033) and in particular, more infection-related admissions (P = 0.001). They were less likely to survive the follow-up period (P = 0.012) and had substantially more bacteremia (P <0.001). Following multivariable analysis, swab positivity remained an independent risk factor for mortality. MRSA and MSSA colonization in patients is associated with significant mortality and morbidity in dialysis patients. Patients dialyzing with lines are also more likely to colonize compared to those with more permanent forms of vascular access.
终末期肾病患者易受感染,尤其是耐甲氧西林金黄色葡萄球菌(MRSA)感染。尽管已对与MRSA相关的死亡率和发病率进行了研究,但对甲氧西林敏感金黄色葡萄球菌(MSSA)的研究程度尚不及此。对578例慢性血液透析患者进行了18个月的回顾性随访。开展了MRSA和MSSA的常规筛查。288例患者(49%)至少有一次MSSA或MRSA拭子检测呈阳性。阳性组和阴性组在年龄、查尔森指数、糖尿病、性别、种族、贫困指数或透析时间方面无统计学差异。然而,阳性患者的动静脉内瘘较少,中心静脉导管较多(P = 0.025)。二元逻辑回归显示,体重指数大于30的患者金黄色葡萄球菌定植风险显著增加(P = 0.044,比值比[OR] 1.856[95%置信区间1.016 - 3.397])。那些使用临时血管通路导管进入研究的患者定植风险也更高(P = 0.029,OR 2.174[95%CI 1.084 - 4.359])。拭子检测呈阳性的患者住院次数显著更多(P = 0.033),尤其是与感染相关的住院次数更多(P = 0.001)。他们在随访期内存活的可能性较小(P = 0.012),菌血症也明显更多(P <0.001)。多变量分析后,拭子阳性仍然是死亡的独立危险因素。患者体内MRSA和MSSA定植与透析患者的显著死亡率和发病率相关。与采用更永久性血管通路形式的患者相比,使用中心静脉导管进行透析的患者也更易发生定植。